Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2065204768', 'doi': 'https://doi.org/10.1517/14656560903302265', 'title': 'Vildagliptin in clinical practice: a review of literature', 'display_name': 'Vildagliptin in clinical practice: a review of literature', 'publication_year': 2009, 'publication_date': '2009-10-30', 'ids': {'openalex': 'https://openalex.org/W2065204768', 'doi': 'https://doi.org/10.1517/14656560903302265', 'mag': '2065204768', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/19874253'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/14656560903302265', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S52020611', 'display_name': 'Expert Opinion on Pharmacotherapy', 'issn_l': '1465-6566', 'issn': ['1465-6566', '1744-7666'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5025576102', 'display_name': 'Moulinath Banerjee', 'orcid': 'https://orcid.org/0000-0003-0456-1967'}, 'institutions': [{'id': 'https://openalex.org/I4210092852', 'display_name': 'Manchester University NHS Foundation Trust', 'ror': 'https://ror.org/00he80998', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210092852']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Moulinath Banerjee', 'raw_affiliation_strings': ['Central Manchester University Hospitals Foundation Trust, Department of Medicine, Manchester, M13 9WL, UK.'], 'affiliations': [{'raw_affiliation_string': 'Central Manchester University Hospitals Foundation Trust, Department of Medicine, Manchester, M13 9WL, UK.', 'institution_ids': ['https://openalex.org/I4210092852']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029102291', 'display_name': 'Naveed Younis', 'orcid': 'https://orcid.org/0000-0003-4747-7095'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Naveed Younis', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5002617335', 'display_name': 'Handrean Soran', 'orcid': 'https://orcid.org/0000-0003-1714-5014'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Handrean Soran', 'raw_affiliation_strings': [], 'affiliations': []}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.911, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 36, 'citation_normalized_percentile': {'value': 0.666866, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '10', 'issue': '16', 'first_page': '2745', 'last_page': '2757'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11339', 'display_name': 'Role of AMP-Activated Protein Kinase in Cellular Metabolism', 'score': 0.9971, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10839', 'display_name': 'Pancreatic Islet Dysfunction and Regeneration', 'score': 0.995, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/vildagliptin', 'display_name': 'Vildagliptin', 'score': 0.98823845}, {'id': 'https://openalex.org/keywords/drug-class', 'display_name': 'Drug class', 'score': 0.5197591}, {'id': 'https://openalex.org/keywords/type-2-diabetes', 'display_name': 'Type 2 Diabetes', 'score': 0.490533}, {'id': 'https://openalex.org/keywords/clinical-practice', 'display_name': 'Clinical Practice', 'score': 0.46445465}], 'concepts': [{'id': 'https://openalex.org/C2776453732', 'wikidata': 'https://www.wikidata.org/wiki/Q421042', 'display_name': 'Vildagliptin', 'level': 4, 'score': 0.98823845}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.923012}, {'id': 'https://openalex.org/C2910068830', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 Diabetes Mellitus', 'level': 3, 'score': 0.6867511}, {'id': 'https://openalex.org/C2778176773', 'wikidata': 'https://www.wikidata.org/wiki/Q2976049', 'display_name': 'Drug class', 'level': 3, 'score': 0.5197591}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.5119237}, {'id': 'https://openalex.org/C177713679', 'wikidata': 'https://www.wikidata.org/wiki/Q679690', 'display_name': 'Intensive care medicine', 'level': 1, 'score': 0.4793216}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.475504}, {'id': 'https://openalex.org/C2779974597', 'wikidata': 'https://www.wikidata.org/wiki/Q28448986', 'display_name': 'Clinical Practice', 'level': 2, 'score': 0.46445465}, {'id': 'https://openalex.org/C156490143', 'wikidata': 'https://www.wikidata.org/wiki/Q412214', 'display_name': 'Dipeptidyl peptidase-4', 'level': 4, 'score': 0.46251595}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.4170862}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.35719234}, {'id': 'https://openalex.org/C512399662', 'wikidata': 'https://www.wikidata.org/wiki/Q3505712', 'display_name': 'Family medicine', 'level': 1, 'score': 0.18993527}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.16023585}], 'mesh': [{'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D001786', 'descriptor_name': 'Blood Glucose', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001786', 'descriptor_name': 'Blood Glucose', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007515', 'descriptor_name': 'Islets of Langerhans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007515', 'descriptor_name': 'Islets of Langerhans', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000077597', 'descriptor_name': 'Vildagliptin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/14656560903302265', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S52020611', 'display_name': 'Expert Opinion on Pharmacotherapy', 'issn_l': '1465-6566', 'issn': ['1465-6566', '1744-7666'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/19874253', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.83, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 70, 'referenced_works': ['https://openalex.org/W1916480346', 'https://openalex.org/W1964833049', 'https://openalex.org/W1967477040', 'https://openalex.org/W1969389642', 'https://openalex.org/W1970406523', 'https://openalex.org/W1970498822', 'https://openalex.org/W1973383046', 'https://openalex.org/W1975588287', 'https://openalex.org/W1976403777', 'https://openalex.org/W1977619586', 'https://openalex.org/W1978691530', 'https://openalex.org/W1982778753', 'https://openalex.org/W1984588810', 'https://openalex.org/W1989976483', 'https://openalex.org/W1991565451', 'https://openalex.org/W1993287695', 'https://openalex.org/W2000083483', 'https://openalex.org/W2013277831', 'https://openalex.org/W2020638064', 'https://openalex.org/W2024567427', 'https://openalex.org/W2027249582', 'https://openalex.org/W2032939032', 'https://openalex.org/W2033198459', 'https://openalex.org/W2033665483', 'https://openalex.org/W2036167841', 'https://openalex.org/W2036912696', 'https://openalex.org/W2038445107', 'https://openalex.org/W2039779698', 'https://openalex.org/W2041608697', 'https://openalex.org/W2042457844', 'https://openalex.org/W2043121816', 'https://openalex.org/W2043326088', 'https://openalex.org/W2047353065', 'https://openalex.org/W2049323977', 'https://openalex.org/W2050456578', 'https://openalex.org/W2063976195', 'https://openalex.org/W2064900976', 'https://openalex.org/W2074925580', 'https://openalex.org/W2075746385', 'https://openalex.org/W2079787842', 'https://openalex.org/W2089443047', 'https://openalex.org/W2093303670', 'https://openalex.org/W2093528927', 'https://openalex.org/W2096857379', 'https://openalex.org/W2099677425', 'https://openalex.org/W2101293928', 'https://openalex.org/W2103828712', 'https://openalex.org/W2109077746', 'https://openalex.org/W2109157463', 'https://openalex.org/W2117762041', 'https://openalex.org/W2117891623', 'https://openalex.org/W2119114384', 'https://openalex.org/W2124020657', 'https://openalex.org/W2124465362', 'https://openalex.org/W2132948641', 'https://openalex.org/W2135349217', 'https://openalex.org/W2137471483', 'https://openalex.org/W2140047096', 'https://openalex.org/W2140369318', 'https://openalex.org/W2143014102', 'https://openalex.org/W2146085551', 'https://openalex.org/W2146901298', 'https://openalex.org/W2147679298', 'https://openalex.org/W2152898312', 'https://openalex.org/W2152978153', 'https://openalex.org/W2154615287', 'https://openalex.org/W2165765596', 'https://openalex.org/W2167621077', 'https://openalex.org/W2325442204', 'https://openalex.org/W2409113257'], 'related_works': ['https://openalex.org/W4380152017', 'https://openalex.org/W2804781071', 'https://openalex.org/W2594161256', 'https://openalex.org/W2590247343', 'https://openalex.org/W2331274473', 'https://openalex.org/W2167621077', 'https://openalex.org/W2075487053', 'https://openalex.org/W2065204768', 'https://openalex.org/W2018705690', 'https://openalex.org/W1985209815'], 'abstract_inverted_index': {'Vildagliptin': [0], 'is': [1], 'the': [2, 6, 14, 34, 43, 50, 54, 59], 'second': [3], 'member': [4], 'of': [5, 10, 16, 25, 36, 52, 56], 'DPP-IV': [7], 'inhibitor': [8], 'class': [9], 'drugs': [11, 27, 60], 'licensed': [12], 'for': [13], 'treatment': [15], 'type': [17], '2': [18], 'diabetes': [19], 'mellitus': [20], '(T2DM).': [21], 'The': [22], 'novel': [23], 'action': [24], 'these': [26], 'has': [28], 'promoted': [29], 'a': [30], 'new': [31], 'outlook': [32], 'in': [33], 'pathobiology': [35], 'T2DM.': [37], 'This': [38], 'review': [39], 'undertakes': [40], 'to': [41, 47, 65], 'examine': [42], 'clinical': [44], 'studies': [45], 'published': [46], 'date,': [48], 'with': [49], 'aim': [51], 'evaluating': [53], 'position': [55], 'vildagliptin': [57], 'among': [58], 'that': [61], 'are': [62], 'now': [63], 'available': [64], 'treat': [66], 'this': [67], 'common': [68], 'dysmetabolic': [69], 'state.': [70]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2065204768', 'counts_by_year': [{'year': 2023, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 3}, {'year': 2013, 'cited_by_count': 5}, {'year': 2012, 'cited_by_count': 2}], 'updated_date': '2024-09-09T16:35:29.613281', 'created_date': '2016-06-24'}